Long Haulers is not going away anytime soon. It is
Post# of 148154
Leronlimab can reset the immune system like no other drug including, of course, Maraviroc. The sufferers of ME/CFS often cannot participate in the workforce and, thus, their contribution to the economic well being of us all is impacted. This must be recognized when calculating the benefit of Leronlimab to society and costs to the medical system.
Then, of course, the cost to society of all those suffering from other indications that can be treated by Leronlimab and the need for treatment of other diseases yet to evolve and you should begin to see why trials of Leronlimab to treat Long Haulers should continue.
I wouldn't count those trials out as time goes on. Reconsideration is always possible, especially if financing for trials becomes available.